News
2h
Asianet Newsable on MSNEli Lilly Hits Dual Wins: Orforglipron, Efsitora Meet Phase 3 Goals For Blood Sugar, Weight Loss And Diabetes CareEfsitora matched or exceeded A1C reductions seen with daily basal insulin across three trials, while orforglipron ...
New data from a Phase 3 trial show that the daily anti-obesity pill may be as safe and effective as drugs like Mounjaro and ...
Novo Nordisk reported mostly mild side effects from its experimental weight-loss drug CagriSema, though results upset ...
Eli Lilly said on Saturday its experimental pill orforglipron helped diabetics lose weight and lower their blood sugar, and ...
Eli Lilly & Co.’s experimental weight-loss pill helped patients shed pounds without serious side effects in a clinical trial, ...
Starting July 7, 2025, the two highest doses of Zepbound will be available for a flat price of $499 per month, with shipments ...
An obesity drug from China helped patients lose a lot of weight in a late-stage clinical trial, making it a prospective new ...
The U.S. Department of Agriculture considers vaccinating poultry against bird flu amidst a major animal-health crisis, with ...
2don MSN
Eli Lilly said the response for its blockbuster drug Mounjaro has been "positive" in India, adding that it is focusing on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results